


default search action
17. PSB 2012: Kohala Coast, Hawaii, USA
- Russ B. Altman, A. Keith Dunker, Lawrence Hunter, Tiffany Murray, Teri E. Klein:
Biocomputing 2012: Proceedings of the Pacific Symposium, Kohala Coast, Hawaii, USA, January 3-7, 2012. World Scientific Publishing 2012, ISBN 978-1-61839-811-6
Identification of Aberrant Pathway and Network Activity from High-Throughput Data
- Rachel Karchin, Michael F. Ochs, Joshua M. Stuart, Joel S. Bader:
Session Introduction. 1-6 - Nirmalya Bandyopadhyay, Sanjay Ranka, Tamer Kahveci:
SSLPred : Predicting Synthetic Sickness Lethality. 7-18 - Gregory W. Carter, Michelle Hays, Song Li, Timothy Galitski:
Predicting the Effects of Copy-Number Variation in Double and Triple Mutant Combinations. 19-30 - Li Chen, Jianhua Xuan, Jinghua Gu, Yue Wang, Zhen Zhang, Tian-Li Wang, Ie-Ming Shih:
Integrative Network Analysis to Identify Aberrant Pathway Networks in Ovarian Cancer. 31-42 - Shahin Mohammadi, Giorgios Kollias, Ananth Grama:
Role of Synthetic Genetic Interactions in Understanding Functional Interactions Among Pathways. 43-54 - Fabio Vandin, Patrick Clay, Eli Upfal, Benjamin J. Raphael:
Discovery of Mutated Subnetworks Associated with Clinical Data in Cancer. 55-66
Intrinsically Disordered Proteins: Analysis, Prediction, Simulation, and Biology
- Jianhan Chen, Jianlin Cheng, A. Keith Dunker:
Session introduction. 67-69 - Virginia M. Burger, Arvind Ramanathan, Andrej J. Savol, Christopher B. Stanley, Pratul K. Agarwal, Chakra S. Chennubhotla:
Quasi-Anharmonic Analysis Reveals Intermediate States in the Nuclear Co-Activator Receptor Binding Domain Ensemble. 70-81 - Charles K. Fisher, Orly Ullman, Collin M. Stultz:
Efficient Construction of Disordered Protein Ensembles in a Bayesian Framework with Optimal Selection of Conformations. 82-93 - Jianjiong Gao, Dong Xu:
Correlation Between Posttranslational Modification and Intrinsic Disorder in Protein. 94-103 - Xin Guo, Martha L. Bulyk, Alexander J. Hartemink:
Intrinsic Disorder Within and Flanking the DNA-Binding Domains of Human Transcription Factors. 104-115 - Wei-Lun Hsu, Christopher J. Oldfield, Jingwei Meng, Fei Huang, Bin Xue, Vladimir N. Uversky, Pedro Romero, A. Keith Dunker:
Intrinsic Protein Disorder and Protein-Protein Interactions. 116-127 - Fei Huang, Christopher J. Oldfield, Jingwei Meng, Wei-Lun Hsu, Bin Xue, Vladimir N. Uversky, Pedro Romero, A. Keith Dunker:
Subclassifying Disordered Proteins by the CH-CDF Plot Method. 128-139 - Chan-seok Jeong, Dongsup Kim:
Coevolved Residues and the Functional Association for Intrinsically Disordered Proteins. 140-151 - Diana M. Mitrea, Richard W. Kriwacki:
Cryptic Disorder: An Order-Disorder Transformation Regulates the Function of Nucleophosmin. 152-163 - Ashwini Patil, Shunsuke Teraguchi, Huy Dinh, Kenta Nakai, Daron M. Standley:
Functional Annotation of Intrinsically Disordered Domains by Their Amino Acid Content Using IDD Navigator. 164-175 - Zhenling Peng, Lukasz A. Kurgan:
On the Complementarity of the Consensus-Based Disorder Prediction. 176-187 - Dana Vuzman, Yonit Hoffman, Yaakov Levy:
Modulating Protein-DNA Interactions by Post-Translational Modifications at Disordered Regions. 188-199
Microbiome Studies: Analytical Tools and Techniques
- James A. Foster, Jason H. Moore, Jack A. Gilbert, John Bunge:
Session introduction. 200-202 - John Bunge, Dankmar Böhning, Heather K. Allen, James A. Foster:
Estimating Population Diversity with Unreliable Low Frequency Counts. 203-212 - Julia Fukuyama, Paul J. McMurdie, Les Dethlefsen, David A. Relman, Susan P. Holmes:
Comparisons of Distance Methods for Combining Covariates and Abundances in Microbiome Studies. 213-224 - Alys Hugo, Douglas J. Baxter, William R. Cannon, Ananth Kalyanaraman, Gaurav Ramesh Kulkarni, Stephen J. Callister:
Proteotyping of Microbial Communities by Optimization of Tandem Mass Spectrometry Data Interpretation. 225-234 - Paul J. McMurdie, Susan P. Holmes:
phyloseq: A Bioconductor Package for Handling and Analysis of High-Throughput Phylogenetic Sequence Data. 235-246 - Siavash Mirarab, Nam Nguyen, Tandy J. Warnow:
SEPP: SATe -Enabled Phylogenetic Placement. 247-258 - Quan Zhang, Thomas G. Doak, Yuzhen Ye:
Artificial Functional Difference Between Microbial Communities Caused by Length Difference of Sequencing Reads. 259-270 - Yuan Zhang, Yanni Sun:
MetaDomain: A Profile HMM-Based Protein Domain Classification Tool for Short Sequences. 271-282
Modeling Host-Pathogen Interactions: Computational Biology And Bioinformatics For Infectious Disease Research
- Jason E. McDermott, Pascal Braun, Richard Bonneau, Daniel R. Hyduke:
Session introduction. 283-286 - Eric A. Franzosa, Yu Xia:
Structural Models for Host-Pathogen Protein-Protein Interactions: Assessing Coverage and Bias. 287-298 - Raluca Gordân, Saumyadipta Pyne, Martha L. Bulyk:
Identification of Cell Cycle-Regulated, Putative Hyphal Genes in Candida Albicans. 299-310 - Ilia Nouretdinov, Alex Gammerman, Yanjun Qi, Judith Klein-Seetharaman:
Determining Confidence of Predicted Interactions Between HIV-1 and Human Proteins Using Conformal Method. 311-322
Personalized Medicine: From Genotypes and Molecular Phenotypes Towards Computed Therapy
- Oliver Stegle, Frederick P. Roth, Quaid Morris, Jennifer Listgarten:
Session introduction. 323-326 - Ross E. Curtis, Junming Yin, Peter Kinnaird, Eric P. Xing:
Finding Genome-Transcriptome-Phenome Associations with Structured Association Mapping and Visualization in GenAMap. 327-338 - Konrad J. Karczewski, Robert P. Tirrell, Pablo Cordero, Nicholas P. Tatonetti, Joel T. Dudley, Keyan Salari, Michael Snyder, Russ B. Altman, Stuart K. Kim:
Interpretome: A Freely Available, Modular, and Secure Personal Genome Interpretation Engine. 339-350 - Ranadip Pal, Noah Berlow:
A Kinase Inhibition Map Approach for Tumor Sensitivity Prediction and Combination Therapy Design for Targeted Drugs. 351-362 - David Warde-Farley, Michael Brudno, Quaid Morris, Anna Goldenberg:
Mixture Model for Sub-Phenotyping in GWAS. 363-374
Text and Knowledge Mining for Pharmacogenomics: Genotypephenotype-Drug Relationships
- Kevin Bretonnel Cohen, Yael Garten, Nigam Shah, Udo Hahn:
Session introduction. 375 - Ekaterina Buyko, Elena Beisswanger, Udo Hahn:
The Extraction of Pharmacogenetic and Pharmacogenomic Relations - A Case Study Using PharmGKB. 376-387 - Robert Hoehndorf, Anika Oellrich, Dietrich Rebholz-Schuhmann, Paul N. Schofield, Georgios V. Gkoutos:
Linking PharmGKB to Phenotype Studies and Animal Models of Disease for Drug Repurposing. 388-399 - Jyotishman Pathak, Laura C. Weiss, Matthew J. Durski, Qian Zhu, Robert R. Freimuth, Christopher G. Chute:
Integrating VA's NDF-RT Drug Terminology with PharmGKB: Preliminary Results. 400-409 - Bethany Percha, Yael Garten, Russ B. Altman:
Discovery and Explanation of Drug-Drug Interactions via Text Mining. 410-421 - Yonghui Wu, Mei Liu, W. Jim Zheng, Zhongming Zhao, Hua Xu:
Ranking Gene-Drug Relationships in Biomedical Literature Using Latent Dirichlet Allocation. 422-433
Workshops
- William Stafford Noble, C. Anthony Blau, Job Dekker, Zhi-jun Duan, Yi Mao:
The Structure and Function of Chromatin and Chromosomes. 434-440 - Gregory Hampikian, Eric M. Meslin:
Law, Bioethics and the Current Status of Ownership, Privacy, Informed Consent in the Genomic Age. 441 - Marylyn D. Ritchie, Nancy J. Cox, Cheng Cheng, Scott Weiss, Teri E. Klein, Russ B. Altman:
Systems Pharmacogenomics-Bridging the Gap. 442

manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.